Participants 617 635 11
84 evaluable women
Participants 693 701 11
89 women
Participants 769 781 3
LNG/EE group
Participants 988 1000 3
LNG/EE group
Participants 1082 1117 3
NETA/EE group, 10% were amenorrheic
Participants 1229 1263 3
cycles 2 and 3 in the LNG/EE group
